1. Home
  2. RPD vs ANIP Comparison

RPD vs ANIP Comparison

Compare RPD & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPD
  • ANIP
  • Stock Information
  • Founded
  • RPD 2000
  • ANIP 2001
  • Country
  • RPD United States
  • ANIP United States
  • Employees
  • RPD N/A
  • ANIP N/A
  • Industry
  • RPD Computer Software: Prepackaged Software
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • RPD Technology
  • ANIP Health Care
  • Exchange
  • RPD Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • RPD 1.5B
  • ANIP 1.4B
  • IPO Year
  • RPD 2015
  • ANIP N/A
  • Fundamental
  • Price
  • RPD $20.91
  • ANIP $89.69
  • Analyst Decision
  • RPD Hold
  • ANIP Strong Buy
  • Analyst Count
  • RPD 19
  • ANIP 9
  • Target Price
  • RPD $28.11
  • ANIP $82.89
  • AVG Volume (30 Days)
  • RPD 975.3K
  • ANIP 621.8K
  • Earning Date
  • RPD 08-07-2025
  • ANIP 08-08-2025
  • Dividend Yield
  • RPD N/A
  • ANIP N/A
  • EPS Growth
  • RPD N/A
  • ANIP N/A
  • EPS
  • RPD 0.43
  • ANIP N/A
  • Revenue
  • RPD $855,361,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • RPD $2.82
  • ANIP $31.40
  • Revenue Next Year
  • RPD $3.94
  • ANIP $7.38
  • P/E Ratio
  • RPD $48.53
  • ANIP N/A
  • Revenue Growth
  • RPD 4.67
  • ANIP 38.68
  • 52 Week Low
  • RPD $17.83
  • ANIP $52.50
  • 52 Week High
  • RPD $44.48
  • ANIP $90.23
  • Technical
  • Relative Strength Index (RSI)
  • RPD 49.95
  • ANIP 84.59
  • Support Level
  • RPD $17.83
  • ANIP $62.61
  • Resistance Level
  • RPD $20.86
  • ANIP $90.23
  • Average True Range (ATR)
  • RPD 1.00
  • ANIP 3.16
  • MACD
  • RPD 0.07
  • ANIP 2.59
  • Stochastic Oscillator
  • RPD 68.99
  • ANIP 93.52

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: